Javascript must be enabled to continue!
Mathematical modelling for spatial optimization of irradiation during proton radiotherapy with nanosensitizers
View through CrossRef
Abstract
A spatially distributed mathematical model is presented that simulates the growth of a non-invasive tumour undergoing treatment by fractionated proton therapy with the use of non-radioactive tumour-specific nanosensitizers. Nanosensitizers are injected intravenously before each irradiation to increase the locally deposited dose via a chain of reactions with therapeutic protons. Modelling simulations show that the use of nanosensitizers allows increasing treatment efficacy. However, their effect is restricted by the necessity of decreasing the energy deposited in tumour in order to comply to the normal damage restrictions. Normalization of tumour microvasculature that accompanies the treatment, also compromises nanosensitizers effect as it impairs their inflow in tumour. It is shown that spatial optimization of irradiation, with conservation of total dose deposited in tumour, can increase tumour cell damage for each single irradiation. However, eventually it may not lead to the overall increase of treatment efficacy, in terms of minimization of the number of remaining viable tumour cells, due to the influence of tumour cell repopulation between irradiations. It is suggested that an efficient way towards minimization of tumour cell repopulation may be the faster suppression of angiogenesis by eradication of metabolically deprived tumour cells. This method can be efficient even despite the fact that it would also cause the decrease of supply of nanosensitizers into the tumour.
Walter de Gruyter GmbH
Title: Mathematical modelling for spatial optimization of irradiation during proton radiotherapy with nanosensitizers
Description:
Abstract
A spatially distributed mathematical model is presented that simulates the growth of a non-invasive tumour undergoing treatment by fractionated proton therapy with the use of non-radioactive tumour-specific nanosensitizers.
Nanosensitizers are injected intravenously before each irradiation to increase the locally deposited dose via a chain of reactions with therapeutic protons.
Modelling simulations show that the use of nanosensitizers allows increasing treatment efficacy.
However, their effect is restricted by the necessity of decreasing the energy deposited in tumour in order to comply to the normal damage restrictions.
Normalization of tumour microvasculature that accompanies the treatment, also compromises nanosensitizers effect as it impairs their inflow in tumour.
It is shown that spatial optimization of irradiation, with conservation of total dose deposited in tumour, can increase tumour cell damage for each single irradiation.
However, eventually it may not lead to the overall increase of treatment efficacy, in terms of minimization of the number of remaining viable tumour cells, due to the influence of tumour cell repopulation between irradiations.
It is suggested that an efficient way towards minimization of tumour cell repopulation may be the faster suppression of angiogenesis by eradication of metabolically deprived tumour cells.
This method can be efficient even despite the fact that it would also cause the decrease of supply of nanosensitizers into the tumour.
Related Results
Clonogenic survival measurement of human glioblastoma (U87) cells cultured in 3Dbio-phantom after proton and X-ray irradiations
Clonogenic survival measurement of human glioblastoma (U87) cells cultured in 3Dbio-phantom after proton and X-ray irradiations
Abstract
Background: Glioblastoma multiforme (GBM) is the most malignant brain tumor and is resistant to conventional radiotherapy. Proton radiotherapy utilizes accelerated...
Radiotherapy refusal in breast cancer with breast-conserving surgery
Radiotherapy refusal in breast cancer with breast-conserving surgery
Abstract
Background
Although radiotherapy after breast-conserving surgery has been the standard treatment for breast cancer, some people still refus...
Unraveling the mechanism of proton translocation in the extracellular half-channel of bacteriorhodopsin
Unraveling the mechanism of proton translocation in the extracellular half-channel of bacteriorhodopsin
AbstractBacteriorhodopsin, a light activated protein that creates a proton gradient in halobacteria, has long served as a simple model of proton pumps. Within bacteriorhodopsin, se...
The use of adjuvant radiotherapy in elderly patients with early‐stage breast cancer: Changes in practice patterns after publication of Cancer and Leukemia Group B 9343
The use of adjuvant radiotherapy in elderly patients with early‐stage breast cancer: Changes in practice patterns after publication of Cancer and Leukemia Group B 9343
BACKGROUNDThe Cancer and Leukemia Group B (CALGB) 9343 randomized phase 3 trial established lumpectomy and adjuvant therapy with tamoxifen alone, rather than both radiotherapy and ...
Theoretical Investigation of Proton Diffusion in Dion–Jacobson Layered Perovskite RbBiNb2O7
Theoretical Investigation of Proton Diffusion in Dion–Jacobson Layered Perovskite RbBiNb2O7
Perovskite materials are considered to be promising electrolyte membrane candidates for electrochemical applications owing to their excellent proton- or oxide-ion-conducting proper...
SU‐E‐T‐470: Beam Performance of the Radiance 330 Proton Therapy System
SU‐E‐T‐470: Beam Performance of the Radiance 330 Proton Therapy System
Purpose:The ProTom Radiance 330 proton radiotherapy system is a fully functional, compact proton radiotherapy system that provides advanced proton delivery capabilities. It support...
Risk Factors For Radiation Pneumonitis In Patients With Lymphoma Treated With Chemotherapy and Photon Or Proton Radiotherapy
Risk Factors For Radiation Pneumonitis In Patients With Lymphoma Treated With Chemotherapy and Photon Or Proton Radiotherapy
Abstract
Introduction
As volume-based radiotherapy planning has become a more standard part of combined modality therapy for lym...
Radiotherapy in the Management of Gastrointestinal Stromal Tumors: A Systematic Review
Radiotherapy in the Management of Gastrointestinal Stromal Tumors: A Systematic Review
Gastrointestinal stromal tumors (GISTs) are considered insensitive to radiotherapy. However, a growing number of case reports and case series have shown that some lesions treated b...

